Virios Therapeutics, LLC VIRI

$ 0.19 4.29%

Quarterly report 2024-Q2
added 08-09-2024

Virios Therapeutics, LLC Balance Sheet 2011-2024 | VIRI

Annual Balance Sheet Virios Therapeutics, LLC

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-29.8 M	3.33 M	-30 K	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	3.64 M	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	3.64 M	-	-	-	-	-	-	-	-
Total Current Liabilities	359 K	1.04 M	1.28 M	-	-	-	-	-	-	-	-	-	-
Total Liabilities	359 K	1.04 M	1.28 M	1.53 M	5.26 M	1.33 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-61.5 M	-56.2 M	-43.9 M	-	-17.6 M	-15.1 M	-	-	-	-	-	-	-
Total Assets	4.17 M	8.37 M	15.8 M	31.5 M	316 K	65.9 K	-	-	-	-	-	-	-
Cash and Cash Equivalents	3.32 M	7.03 M	14 M	29.8 M	-	-	-	-	-	-	-	-	-
Book Value	3.81 M	7.33 M	14.5 M	29.9 M	-4.94 M	-1.26 M	-	-	-	-	-	-	-
Total Shareholders Equity	3.81 M	7.33 M	14.5 M	29.9 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Virios Therapeutics, LLC

	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	500 K	359 K	487 K	520 K	549 K	1.04 M	1.63 M	1.9 M	1.88 M	1.28 M	1.23 M	906 K	1.17 M	1.53 M	1.53 M	1.53 M	1.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-63.8 M	-61.5 M	-60.4 M	-59.1 M	-57.7 M	-56.2 M	-54.1 M	-51.6 M	-47.9 M	-43.9 M	-39.4 M	-35.3 M	-31 M	-28 M	-28 M	-28 M	-28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	3.64 M	4.17 M	5.25 M	5.21 M	6.52 M	8.37 M	10.9 M	9.04 M	12.5 M	15.8 M	20.1 M	23.8 M	28.3 M	31.5 M	31.5 M	31.5 M	31.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	3.02 M	3.32 M	4.79 M	4.59 M	5.33 M	7.03 M	9.79 M	7.7 M	11.4 M	14 M	19.2 M	21.8 M	24.6 M	29.8 M	29.8 M	29.8 M	29.8 M	309 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	3.14 M	3.81 M	4.76 M	4.69 M	5.97 M	7.33 M	9.22 M	7.14 M	10.7 M	14.5 M	18.9 M	22.9 M	27.1 M	29.9 M	29.9 M	29.9 M	29.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	3.14 M	3.81 M	4.76 M	4.69 M	5.97 M	7.33 M	9.22 M	7.14 M	10.7 M	14.5 M	18.9 M	22.9 M	27.1 M	29.9 M	29.9 M	29.9 M	29.9 M	-5.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency